Accel Research Sites Network opens new St. Petersburg-Largo Location
The new clinical research unit offers expanded capabilities for patients. Residents of St. Petersburg, Largo, and the greater Tampa Bay Area… Read More
Category: Company News
Tampa Bay Times shares stories of participants in Alzheimer’s trial
At Accel Research Sites, our participants are a huge part of why we do what we do. The Tampa Bay Times… Read More
Lead investigator discusses Novavax approval with Orlando TV station
The FDA recently approved the Novavax vaccine for COVID-19. Dr. Bruce Rankin worked on clinical trials for this vaccine at Accel… Read More
Accel principal investigator shares thoughts on COVID vaccines for young kids
The CDC recently approved Pfizer and Moderna’s COVID-19 vaccines for children as young as 6 months. Dr. Salma Elfaki, a pediatrician… Read More
Accel Research Sites CEO honored among Orlando Magazine Women of the Year
Lora Parahovnik joins prestigious list of 24 woman leaders Read More
Accel Research Sites recruiting for Alzheimer’s prevention trial
Patients ages 55-80 with no symptoms are eligible Read More
The FDA’s new draft guidance on clinical trial diversity
Accel Research Sites looks forward to supporting sponsors, increasing trial diversity Read More
Accel Research Sites honored with inaugural Inno Fire Award, named category Blazer
Clinical trial leader among hot innovators in Orlando Read More
